{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:24Z","timestamp":1707525624354},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,7]]},"DOI":"10.7759\/cureus.51819","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T03:35:05Z","timestamp":1704684905000},"source":"Crossref","is-referenced-by-count":0,"title":["Lupus-Induced Accelerated Heart Failure in a Young African American Female: Cardiovascular and Systemic Complications of Noncompliance to Maintenance Therapy and the Social Determinants of Cardiovascular Disease"],"prefix":"10.7759","author":[{"given":"Ikpechukwu J","family":"Okorie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund","family":"Appiah-Kubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipa","family":"Owusu-Antwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evans","family":"Takyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Ugwendum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annmarie","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Atere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Nfonoyim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos GC","year":"2020","unstructured":"Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020, 21:605-14. 10.1038\/s41590-020-0677-6","journal-title":"Nat Immunol"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000454","article-title":"Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years","volume":"8","author":"Ajeganova S","year":"2021","unstructured":"Ajeganova S, Hafstr\u00f6m I, Frosteg\u00e5rd J. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years. Lupus Sci Med. 2021, 8:","journal-title":"Lupus Sci Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26671","article-title":"Cardiovascular complications in systemic lupus erythematosus","volume":"14","author":"Alghareeb R","year":"2022","unstructured":"Alghareeb R, Hussain A, Maheshwari MV, Khalid N, Patel PD. Cardiovascular complications in systemic lupus erythematosus. Cureus. 2022, 14:e26671. 10.7759\/cureus.26671","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/578390","article-title":"Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review","volume":"2011","author":"Ashrafi R","year":"2011","unstructured":"Ashrafi R, Garg P, McKay E, Gosney J, Chuah S, Davis G. Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review. Cardiol Res Pract. 2011, 2011:578390. 10.4061\/2011\/578390","journal-title":"Cardiol Res Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019191476","article-title":"Diagnosis of myocarditis at cardiac MRI: the continuing quest for improved tissue characterization","volume":"292","author":"de Roos A","year":"2019","unstructured":"de Roos A. Diagnosis of myocarditis at cardiac MRI: the continuing quest for improved tissue characterization. Radiology. 2019, 292:618-9. 10.1148\/radiol.2019191476","journal-title":"Radiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.12.66","article-title":"Hydroxychloroquine-induced cardiomyopathy and heart failure in twins","volume":"10","author":"Zhao H","year":"2018","unstructured":"Zhao H, Wald J, Palmer M, Han Y. Hydroxychloroquine-induced cardiomyopathy and heart failure in twins. J Thorac Dis. 2018, 10:E70-3. 10.21037\/jtd.2017.12.66","journal-title":"J Thorac Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23018","article-title":"Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population\u2010based study","volume":"69","author":"Avi\u00f1a-Zubieta JA","year":"2017","unstructured":"Avi\u00f1a-Zubieta JA, To F, Vostretsova K, De Vera M, Sayre EC, Esdaile JM. Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population\u2010based study. Arthritis Care Res (Hoboken). 2017, 69:849-56. 10.1002\/acr.23018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60(2)","author":"Urowitz MB","year":"1976","unstructured":"Urowitz MB, Bookman AA, Koehler BE, et al.. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976, 60(2):221-5. 10.1016\/0002-9343(76)90431-9","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.24537","article-title":"Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study","volume":"61","author":"Hak AE","year":"2009","unstructured":"Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum. 2009, 61:1396-402. 10.1002\/art.24537","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.03.112","article-title":"Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy","volume":"157","author":"Frustaci A","year":"2012","unstructured":"Frustaci A, Morgante E, Antuzzi D, Russo MA, Chimenti C. Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy. Int J Cardiol. 2012, 157:117-9. 10.1016\/j.ijcard.2012.03.112","journal-title":"Int J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101812","article-title":"Hydroxychloroquine safety: a meta-analysis of randomized controlled trials","volume":"36","author":"Eljaaly K","year":"2020","unstructured":"Eljaaly K, Alireza KH, Alshehri S, Al-Tawfiq JA. Hydroxychloroquine safety: a meta-analysis of randomized controlled trials. Travel Med Infect Dis. 2020, 36:101812. 10.1016\/j.tmaid.2020.101812","journal-title":"Travel Med Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2020.100747","article-title":"Hydroxychloroquine is protective to the heart, not harmful: a systematic review","volume":"37","author":"Prodromos CC","year":"2020","unstructured":"Prodromos CC, Rumschlag T, Perchyk T. Hydroxychloroquine is protective to the heart, not harmful: a systematic review. New Microbes New Infect. 2020, 37:100747. 10.1016\/j.nmni.2020.100747","journal-title":"New Microbes New Infect"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143771","article-title":"Hydroxychloroquine protects against cardiac ischaemia\/reperfusion injury in vivo via enhancement of ERK1\/2 phosphorylation","volume":"10","author":"Bourke L","year":"2015","unstructured":"Bourke L, McCormick J, Taylor V, et al.. Hydroxychloroquine protects against cardiac ischaemia\/reperfusion injury in vivo via enhancement of ERK1\/2 phosphorylation. PLoS One. 2015, 10:e0143771. 10.1371\/journal.pone.0143771","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24155","article-title":"Clinical significance of monitoring hydroxychloroquine levels in patients with systemic lupus erythematosus: a\u00a0systematic review and meta-analysis","volume":"73","author":"Garg S","year":"2021","unstructured":"Garg S, Unnithan R, Hansen KE, Costedoat-Chalumeau N, Bartels CM. Clinical significance of monitoring hydroxychloroquine levels in patients with systemic lupus erythematosus: a\u00a0systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2021, 73:707-16. 10.1002\/acr.24155","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02211-1","article-title":"Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS-evaluation of whole blood, plasma, and serum as sample matrices","volume":"22","author":"Carlsson H","year":"2020","unstructured":"Carlsson H, Hjorton K, Abujrais S, R\u00f6nnblom L, \u00c5kerfeldt T, Kultima K. Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS-evaluation of whole blood, plasma, and serum as sample matrices. Arthritis Res Ther. 2020, 22:125. 10.1186\/s13075-020-02211-1","journal-title":"Arthritis Res Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson GK","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005, 352:1685-95. 10.1056\/NEJMra043430","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.019","article-title":"Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies","volume":"14","author":"Arnaud L","year":"2015","unstructured":"Arnaud L, Mathian A, Devilliers H, et al.. Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies. Autoimmun Rev. 2015, 14:192-200. 10.1016\/j.autrev.2014.10.019","journal-title":"Autoimmun Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2004.08.037","article-title":"Statins and autoimmune diseases","volume":"4","author":"Gurevich VS","year":"2005","unstructured":"Gurevich VS, Shovman O, Slutzky L, Meroni PL, Shoenfeld Y. Statins and autoimmune diseases. Autoimmun Rev. 2005, 4:123-9. 10.1016\/j.autrev.2004.08.037","journal-title":"Autoimmun Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312437270","article-title":"Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort","volume":"21","author":"Willis R","year":"2012","unstructured":"Willis R, Seif AM, McGwin G Jr, et al.. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus. 2012, 21:830-5. 10.1177\/0961203312437270","journal-title":"Lupus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-018-0512-y","article-title":"Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers","volume":"26","author":"Monzavi SM","year":"2018","unstructured":"Monzavi SM, Alirezaei A, Shariati-Sarabi Z, et al.. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers. Inflammopharmacology. 2018, 26:1175-82. 10.1007\/s10787-018-0512-y","journal-title":"Inflammopharmacology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13006","article-title":"Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database","volume":"171","author":"Kuhn A","year":"2014","unstructured":"Kuhn A, Sigges J, Biazar C, et al.. Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database. Br J Dermatol. 2014, 171:571-9. 10.1111\/bjd.13006","journal-title":"Br J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/art.24538","article-title":"Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort","volume":"61","author":"Pons-Estel GJ","year":"2009","unstructured":"Pons-Estel GJ, Alarc\u00f3n GS, McGwin G Jr, et al.. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum. 2009, 61:830-9. 10.1002\/art.24538","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025591","article-title":"Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review","volume":"100","author":"Meridor K","year":"2021","unstructured":"Meridor K, Shoenfeld Y, Tayer-Shifman O, Levy Y. Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review. Medicine (Baltimore). 2021, 100:e25591. 10.1097\/MD.0000000000025591","journal-title":"Medicine (Baltimore)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X16666201014144022","article-title":"Cardiac complications attributed to hydroxychloroquine: a systematic review of the literature pre-COVID-19","volume":"17","author":"Fram G","year":"2021","unstructured":"Fram G, Wang DD, Malette K, et al.. Cardiac complications attributed to hydroxychloroquine: a systematic review of the literature pre-COVID-19. Curr Cardiol Rev. 2021, 17:319-27. 10.2174\/1573403X16666201014144022","journal-title":"Curr Cardiol Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.81.2.221","article-title":"Chloroquine cardiomyopathy with conduction disorders","volume":"81","author":"Baguet JP","year":"1999","unstructured":"Baguet JP, Tremel F, Fabre M. Chloroquine cardiomyopathy with conduction disorders. Heart. 1999, 81:221-3. 10.1136\/hrt.81.2.221","journal-title":"Heart"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319811","article-title":"Social determinants of cardiovascular disease","volume":"130","author":"Powell-Wiley TM","year":"2022","unstructured":"Powell-Wiley TM, Baumer Y, Baah FO, et al.. Social determinants of cardiovascular disease. Circ Res. 2022, 130:782-99. 10.1161\/CIRCRESAHA.121.319811","journal-title":"Circ Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06268-y","article-title":"Health disparities in systemic lupus erythematosus-a narrative review","volume":"41","author":"Hasan B","year":"2022","unstructured":"Hasan B, Fike A, Hasni S. Health disparities in systemic lupus erythematosus-a narrative review. Clin Rheumatol. 2022, 41:3299-311. 10.1007\/s10067-022-06268-y","journal-title":"Clin Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.0385","article-title":"The burden of cardiovascular diseases among US States, 1990-2016","volume":"3","author":"Roth GA","year":"2018","unstructured":"Roth GA, Johnson CO, Abate KH, et al.. The burden of cardiovascular diseases among US States, 1990-2016. JAMA Cardiol. 2018, 3:375-89. 10.1001\/jamacardio.2018.0385","journal-title":"JAMA Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302133","article-title":"The effect of neighborhood socioeconomic status on education and health outcomes for children living in social housing","volume":"104","author":"Martens PJ","year":"2014","unstructured":"Martens PJ, Chateau DG, Burland EM, et al.. The effect of neighborhood socioeconomic status on education and health outcomes for children living in social housing. Am J Public Health. 2014, 104:2103-13. 10.2105\/AJPH.2014.302133","journal-title":"Am J Public Health"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.09.011","article-title":"Socioeconomic determinants of health and cardiovascular outcomes in women: JACC review topic of the week","volume":"78","author":"Lindley KJ","year":"2021","unstructured":"Lindley KJ, Aggarwal NR, Briller JE, et al.. Socioeconomic determinants of health and cardiovascular outcomes in women: JACC review topic of the week. J Am Coll Cardiol. 2021, 78:1919-29. 10.1016\/j.jacc.2021.09.011","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24080","article-title":"Impact of the affordable care act Medicaid expansion on access to care and hospitalization charges for lupus patients","volume":"72","author":"Brown EA","year":"2020","unstructured":"Brown EA, Dismuke-Greer CE, Ramakrishnan V, Faith TD, Williams EM. Impact of the affordable care act Medicaid expansion on access to care and hospitalization charges for lupus patients. Arthritis Care Res (Hoboken). 2020, 72:208-15. 10.1002\/acr.24080","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-017-0179-8","article-title":"Implicit bias in healthcare professionals: a systematic review","volume":"18","author":"FitzGerald C","year":"2017","unstructured":"FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017, 18:19. 10.1186\/s12910-017-0179-8","journal-title":"BMC Med Ethics"},{"key":"ref33","article-title":"Representation in clinical trials: a review on reaching underrepresented populations in research","volume":"34","author":"Yates I","year":"2020","unstructured":"Yates I, Byrne J, Donahue S, McCarty L, Mathews A. Representation in clinical trials: a review on reaching underrepresented populations in research. Clin researcher. 2020, 34:","journal-title":"Clin researcher"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2006.04.002","article-title":"Major depressive disorder and disease activity in systemic lupus erythematosus","volume":"48","author":"Nery FG","year":"2007","unstructured":"Nery FG, Borba EF, Hatch JP, Soares JC, Bonf\u00e1 E, Neto FL. Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry. 2007, 48:14-9. 10.1016\/j.comppsych.2006.04.002","journal-title":"Compr Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-04236-z","article-title":"A cross-sectional study on the association of anxiety and depression with the disease activity of systemic lupus erythematosus","volume":"22","author":"Liao J","year":"2022","unstructured":"Liao J, Kang J, Li F, et al.. A cross-sectional study on the association of anxiety and depression with the disease activity of systemic lupus erythematosus. BMC Psychiatry. 2022, 22:591. 10.1186\/s12888-022-04236-z","journal-title":"BMC Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011376","article-title":"Depression and anxiety in systemic lupus erythematosus: the crosstalk between immunological, clinical, and psychosocial factors","volume":"97","author":"Figueiredo-Braga M","year":"2018","unstructured":"Figueiredo-Braga M, Cornaby C, Cortez A, et al.. Depression and anxiety in systemic lupus erythematosus: the crosstalk between immunological, clinical, and psychosocial factors. Medicine (Baltimore). 2018, 97:e11376. 10.1097\/MD.0000000000011376","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/197529-lupus-induced-accelerated-heart-failure-in-a-young-african-american-female-cardiovascular-and-systemic-complications-of-noncompliance-to-maintenance-therapy-and-the-social-determinants-of-cardiovascular-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:16:22Z","timestamp":1707509782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/197529-lupus-induced-accelerated-heart-failure-in-a-young-african-american-female-cardiovascular-and-systemic-complications-of-noncompliance-to-maintenance-therapy-and-the-social-determinants-of-cardiovascular-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,7]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.51819","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,7]]}}}